dsip 15mg Vial | BioHack London DSIP Dosage Chart – 5

The original characterization by the Sikiri group framed the larger parent protein in human gastric juice as a protective factor for the gastrointestinal mucosa, with body protection compound (BPC) referring to that broader protective role

PMID: 12577695

Observed Side Effects (From Clinical Trials) In the Lancet 2021 Phase 2 trial (n=706), at the highest 4.5 mg/week dose, 88% of participants reported at least one side effect and 63% reported a GI-specific event

These combination data support the hypothesis that dual targeting of amylin receptor and GLP-1 receptor pathways which engage anatomically and mechanistically distinct neural circuits can produce synergistic metabolic outcomes in preclinical and clinical models